The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The 50-page lawsuit claims the actions of the labs has violated state law, intentionally interfered with MCR’s business ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
The Framingham facility alleges that labs who manipulate cannabis safety testing are enriching themselves at their expense.
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.